![](/img/cover-not-exists.png)
EGFR-Mutated Lung Cancers Resistant to Osimertinib through EGFR C797S Respond to First-Generation Reversible EGFR Inhibitors but Eventually Acquire EGFR T790M/C797S in Preclinical Models and Clinical Samples
Rangachari, Deepa, To, Ciric, Shpilsky, Jason E., VanderLaan, Paul A., Kobayashi, Susumu S., Mushajiang, Mierzhati, Lau, Christie J., Paweletz, Cloud P., Oxnard, Geoffrey R., Jänne, Pasi A., Costa, DaVolume:
14
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2019.07.016
Date:
November, 2019
File:
PDF, 1.39 MB
english, 2019